Prothena Corporation PLC
NASDAQ:PRTA

Watchlist Manager
Prothena Corporation PLC Logo
Prothena Corporation PLC
NASDAQ:PRTA
Watchlist
Price: 5.08 USD 0.2% Market Closed
Market Cap: 273.5m USD

Wall Street
Price Targets

PRTA Price Targets Summary
Prothena Corporation PLC

Wall Street analysts forecast PRTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRTA is 29.58 USD with a low forecast of 4.04 USD and a high forecast of 85.05 USD.

Lowest
Price Target
4.04 USD
20% Downside
Average
Price Target
29.58 USD
482% Upside
Highest
Price Target
85.05 USD
1 574% Upside
Prothena Corporation PLC Competitors:
Price Targets
300676
BGI Genomics Co Ltd
6% Upside
PHARM
Pharming Group NV
545% Upside
INMB
INmune Bio Inc
210% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
13% Downside
TWST
Twist Bioscience Corp
55% Upside
9688
Zai Lab Ltd
17% Upside
KALV
Kalvista Pharmaceuticals Inc
114% Upside
688331
RemeGen Co Ltd
29% Downside

Revenue
Forecast

Revenue Estimate
Prothena Corporation PLC

For the last 8 years the compound annual growth rate for Prothena Corporation PLC's revenue is 82%. The projected CAGR for the next 3 years is 14%.

82%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Prothena Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Prothena Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRTA's stock price target?
Price Target
29.58 USD

According to Wall Street analysts, the average 1-year price target for PRTA is 29.58 USD with a low forecast of 4.04 USD and a high forecast of 85.05 USD.

What is Prothena Corporation PLC's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Prothena Corporation PLC's revenue is 82%. The projected CAGR for the next 3 years is 14%.

Back to Top